ArticleThe EMBO journal2022

Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases.

Valter Bergant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.